clostridium
difficil
common
caus
antibioticassoci
pseudomembran
coliti
induc
sever
recurr
diarrhoea
especi
hospit
human
patient
c
difficil
also
associ
enterocol
diarrhoea
anim
includ
dog
marmoset
metronidazol
effect
antibiot
treatment
c
difficil
infect
cdi
human
anim
howev
recurr
cdi
treatment
antibiot
includ
metronidazol
becom
clinic
problem
human
patient
faecal
microbiota
transplant
fmt
treatment
option
perform
introduc
faecal
microbiota
obtain
healthi
donor
gastrointestin
gi
tract
recipi
success
clinic
outcom
fmt
recurr
cdi
report
human
marmoset
howev
unclear
whether
fmt
effect
treatment
c
difficileassoci
diarrhoea
dog
report
persist
recoveri
c
difficileassoci
diarrhoea
dog
oral
fmt
without
advers
event
sexual
intact
male
french
bulldog
present
day
histori
intermitt
diarrhoea
histori
focal
seizur
observ
almost
everi
day
day
stool
consist
soft
wateri
stool
frequenc
timesday
blood
mucu
observ
faec
thu
diarrhoea
consid
induc
coliti
four
month
prior
current
present
faecal
sampl
dog
subject
realtim
pcr
analysi
idexx
laboratori
inc
tokyo
japan
cryptosporidium
spp
giardia
spp
clostridium
perfringen
toxin
clostridium
difficil
toxin
b
campylobact
jejuni
campylobact
coli
salmonella
spp
canin
parvoviru
type
canin
distemp
viru
canin
enter
coronaviru
gene
veterinari
practition
posit
reaction
campylobact
jejuni
detect
analysi
dog
treat
tylosin
tylan
eli
lilli
japan
kk
kobe
japan
mgkg
po
day
veterinari
practition
howev
stool
condit
improv
administr
antidiarrho
diabust
kyuritsu
tokyo
japan
tablet
po
contain
berberin
tannat
bismuth
subnitr
geranium
herb
nutgal
scopolia
extract
antiflatul
bioymbust
kyuritsu
tokyo
japan
tablet
po
contain
bacillu
coagulan
bifidobacterium
longuin
lactobacillu
acidophilu
streptococcu
faecali
pancreatin
improv
stool
condit
howev
drug
discontinu
diarrhoea
recur
day
physic
clinic
examin
includ
complet
blood
count
cbc
serum
biochem
analysi
radiographi
abdomin
ultrasound
faecal
examin
reveal
specif
caus
chronic
diarrhoea
focal
seizur
faecal
sampl
subject
realtim
pcr
analysi
idexx
laboratori
inc
investig
infecti
caus
diarrhoea
meanwhil
dog
administ
erythromycin
erythromycin
sawai
pharmaceut
osaka
japan
mgkg
po
day
base
posit
result
c
jejuni
infect
month
earlier
day
realtim
pcr
analysi
faecal
sampl
collect
day
found
posit
c
difficil
toxin
b
gene
neg
pathogen
presenc
c
difficil
antigen
toxin
b
protein
faecal
sampl
collect
day
also
confirm
immunochromatograph
test
kit
techlab
c
diff
quick
chek
complet
aler
chiba
japan
followup
visit
day
stool
condit
improv
administr
erythromycin
dog
base
clinic
investig
find
diarrhoea
dog
consid
induc
c
difficileassoci
coliti
treatment
metronidazol
propos
howev
owner
reject
treatment
potenti
metronidazoleinduc
neuropathi
investig
caus
focal
seizur
comput
tomographi
magnet
reson
imag
perform
mild
ventriculomegali
detect
brain
dog
imag
unclear
whether
lesion
relat
seizur
initi
treatment
zonisamid
consav
ds
pharma
anim
health
osaka
japan
mgkg
po
seizur
frequenc
decreas
day
dog
still
larg
bowel
diarrhoea
realtim
pcr
analysi
immunochromatographi
confirm
c
difficil
antigen
toxin
b
gene
protein
still
posit
faecal
sampl
collect
day
therefor
instead
treatment
metronidazol
oral
faecal
microbiota
transplant
fmt
perform
obtain
written
inform
consent
owner
treatment
approv
research
ethic
committe
tokyo
univers
agricultur
technolog
fresh
faec
collect
sexual
intact
healthi
male
beagl
maintain
research
purpos
healthi
dog
hous
cage
fed
commerci
diet
scienc
diet
adult
hill
scolgat
ltd
tokyo
japan
daili
water
provid
ad
libitum
physic
clinic
examin
includ
cbc
serum
biochem
analysi
radiographi
abdomin
ultrasound
faecal
examin
find
abnorm
healthi
dog
realtim
pcr
analysi
faecal
sampl
detect
pathogen
immedi
faecal
collect
approxim
g
faec
dissolv
ml
tap
water
faecal
solut
filter
medic
gauz
pad
twice
total
ml
filter
faecal
solut
obtain
oral
administ
recipi
dog
use
syring
stool
consist
becam
normal
stool
frequenc
reduc
timesday
day
oral
fmt
faecal
blood
mucu
observ
oral
fmt
realtim
pcr
analysi
faecal
sampl
collect
day
oral
fmt
day
neg
c
difficil
toxin
b
gene
realtim
pcr
analysi
faecal
sampl
collect
day
confirm
c
difficil
toxin
b
gene
still
neg
absenc
c
difficil
antigen
toxin
b
protein
also
verifi
faecal
sampl
immunochromatograph
test
kit
oral
fmt
addit
diarrhoea
recur
oral
fmt
medic
unnecessari
stool
condit
still
normal
day
present
case
report
demonstr
c
difficil
antigen
toxin
b
gene
protein
turn
neg
stool
consist
frequenc
faecal
blood
mucu
becam
normal
oral
fmt
dog
larg
bowel
diarrhoea
success
clinic
outcom
fmt
recurr
cdi
report
human
marmoset
find
collect
suggest
correct
gut
microbiota
fmt
use
treatment
option
c
difficileassoci
diarrhoea
across
anim
speci
pathogenesi
cdi
well
establish
human
involv
toxin
product
colon
c
difficil
deplet
nonc
difficil
colon
microbiota
howev
still
controversi
whether
c
difficil
play
patholog
role
develop
diarrhoea
dog
c
difficil
isol
faec
diarrheic
dog
healthi
nondiarrh
dog
variou
incid
rate
depend
sampl
popul
sever
studi
suggest
signific
associ
presenc
c
difficil
toxin
faec
canin
diarrhoea
outbreak
c
difficileassoci
diseas
also
report
small
anim
veterinari
teach
hospit
contrast
previou
studi
fail
reproduc
cdi
healthi
adult
dog
administr
c
difficil
without
antibiot
present
report
realtim
pcr
analysi
immunochromatographi
detect
c
difficil
antigen
toxin
b
gene
protein
faecal
sampl
physic
clinic
examin
identifi
caus
chronic
larg
bowel
diarrhoea
addit
c
difficil
antigen
toxin
b
gene
protein
becam
neg
oral
fmt
diarrhoea
recur
despit
pharmacolog
treatment
base
clinic
molecular
find
diarrhoea
dog
consid
induc
c
difficileassoci
coliti
fmt
perform
via
upper
lower
gi
tract
theoret
guidelin
fmt
recent
propos
dog
cat
recent
studi
report
clinic
efficaci
fmt
puppi
canin
parvoviru
infect
faecal
suspens
infus
proxim
portion
rectum
puppi
retent
enema
sinc
clinic
data
fmt
limit
veterinari
medicin
consensu
regard
appropri
method
faecal
administr
dog
present
case
fmt
perform
oral
administr
faec
dilut
tap
water
oral
fmt
also
shown
effect
treatment
cdi
marmoset
wherebi
faec
mix
marmoset
usual
food
fed
subject
human
patient
cdi
report
case
refractori
lower
gi
deliveri
respond
fmt
via
oral
frozen
faecal
capsul
oral
fmt
much
easier
method
fmt
fmt
endoscopi
nasogastricnasoenter
tube
retent
enema
although
potenti
advantag
disadvantag
exist
fmt
via
upper
lower
gi
tract
present
report
suggest
oral
administr
faecal
solut
use
fmt
method
dog
recipi
dog
report
show
advers
event
oral
fmt
day
recipi
dog
oral
administ
fresh
faecal
solut
prepar
healthi
beagl
abnorm
physic
clinic
examin
faecal
pathogen
metronidazol
report
effect
antibiot
treatment
cdi
dog
human
howev
vitro
analys
show
metronidazoleresist
strain
faec
dog
human
patient
mani
cdi
case
treat
antibiot
includ
metronidazol
report
recur
target
fmt
report
metronidazol
administ
owner
request
unclear
whether
c
difficil
detect
dog
metronidazoleresist
previou
studi
shown
fmt
effect
treatment
antibioticsresist
recurr
cdi
human
cure
rate
marmoset
evalu
effect
fmt
metronidazoleresist
recurr
cdi
dog
studi
requir
mechan
underli
fmt
consid
reestablish
normal
gut
microbiota
host
defens
cdi
previou
studi
show
faecal
microbiota
human
patient
cdi
lower
bacteri
divers
healthi
human
patient
fmt
improv
microbiota
divers
current
report
faecal
microbiota
analyz
dog
cdi
clarifi
mechan
oral
fmt
exert
treatment
effect
cdi
dog
necessari
compar
faecal
microbiota
canin
patient
healthi
dog
evalu
microbiota
canin
patient
oral
fmt
conclus
present
report
reveal
oral
fmt
effect
treatment
c
difficileassoci
diarrhoea
dog
fmt
reintroduc
normal
microbiota
healthi
individu
patient
correct
underli
dysbiosi
gut
previou
studi
report
dysbiosi
associ
acut
chronic
gi
diseas
dog
includ
idiopath
inflammatori
bowel
diseas
find
present
report
provid
rational
evalu
clinic
efficaci
oral
fmt
gi
diseas
dog
